{"id":"https://openalex.org/W4200419901","doi":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17","title":"Prospects for the Use of Combined Lysozyme Drugs in COVID-19","display_name":"Prospects for the Use of Combined Lysozyme Drugs in COVID-19","publication_year":2021,"publication_date":"2021-09-15","ids":{"openalex":"https://openalex.org/W4200419901","doi":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17"},"language":"en","primary_location":{"id":"doi:10.33978/2307-3586-2021-17-24-12-17","doi":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17","is_oa":true,"landing_page_url":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17","pdf_url":"https://umedp.ru/upload/iblock/663/Gorelov.pdf","source":{"id":"https://openalex.org/S4210189136","display_name":"Effective Pharmacotherapy","issn_l":"2307-3586","issn":["2307-3586"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Effective Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://umedp.ru/upload/iblock/663/Gorelov.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033459810","display_name":"Aleksandr V. Gorelov","orcid":"https://orcid.org/0000-0001-9257-0171","observed_orcids":["https://orcid.org/0000-0001-9257-0171"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.V. Gorelov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015660065","display_name":"Denis V. Usenko","orcid":"https://orcid.org/0000-0001-5232-7337","observed_orcids":["https://orcid.org/0000-0001-5232-7337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.V. Usenko","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5232-7337","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037611393","display_name":"Liliya P. Antonova","orcid":"https://orcid.org/0000-0002-1221-1134","observed_orcids":["https://orcid.org/0000-0002-1221-1134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L.P. Antonova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055703679","display_name":"Liubov I. Kozlovskaya","orcid":"https://orcid.org/0000-0002-3029-1035","observed_orcids":["https://orcid.org/0000-0002-3029-1035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L.I. Kozlovskaya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097053379","display_name":"Ye.Yu. Shustova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ye.Yu. Shustova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048022891","display_name":"Viktor P. Volok","orcid":"https://orcid.org/0000-0002-9659-723X","observed_orcids":["https://orcid.org/0000-0002-9659-723X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V.P. Volok","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0848,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.39065742,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"17","issue":"24","first_page":"12","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.444599986076355,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cetylpyridinium-chloride","display_name":"cetylpyridinium chloride","score":0.9900000095367432},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.8600000143051147},{"id":"https://openalex.org/keywords/topical-spray","display_name":"topical spray","score":0.640999972820282},{"id":"https://openalex.org/keywords/vero-cell-culture","display_name":"Vero cell culture","score":0.7409999966621399},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.6880000233650208},{"id":"https://openalex.org/keywords/local-immunity","display_name":"local immunity","score":0.8970000147819519},{"id":"https://openalex.org/keywords/mild-to-moderate-covid-19","display_name":"mild to moderate COVID-19","score":0.7540000081062317},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C2778206598","wikidata":"https://www.wikidata.org/wiki/Q418318","display_name":"Cetylpyridinium chloride","level":3,"score":0.700476348400116},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6809728741645813},{"id":"https://openalex.org/C89138240","wikidata":"https://www.wikidata.org/wiki/Q3066564","display_name":"Vero cell","level":3,"score":0.5631508827209473},{"id":"https://openalex.org/C2776966407","wikidata":"https://www.wikidata.org/wiki/Q24779410","display_name":"Lysozyme","level":2,"score":0.5625863075256348},{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.5264557003974915},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5186318755149841},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.5184504389762878},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.4875447452068329},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4820433557033539},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.47120970487594604},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45128071308135986},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.392054945230484},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3728351593017578},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35327500104904175},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27465736865997314},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16665828227996826},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.10201925039291382},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07062602043151855},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.33978/2307-3586-2021-17-24-12-17","doi":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17","is_oa":true,"landing_page_url":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17","pdf_url":"https://umedp.ru/upload/iblock/663/Gorelov.pdf","source":{"id":"https://openalex.org/S4210189136","display_name":"Effective Pharmacotherapy","issn_l":"2307-3586","issn":["2307-3586"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Effective Pharmacotherapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.33978/2307-3586-2021-17-24-12-17","doi":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17","is_oa":true,"landing_page_url":"https://doi.org/10.33978/2307-3586-2021-17-24-12-17","pdf_url":"https://umedp.ru/upload/iblock/663/Gorelov.pdf","source":{"id":"https://openalex.org/S4210189136","display_name":"Effective Pharmacotherapy","issn_l":"2307-3586","issn":["2307-3586"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Effective Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200419901.pdf","grobid_xml":"https://content.openalex.org/works/W4200419901.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1979295973","https://openalex.org/W2035692177","https://openalex.org/W2036557029","https://openalex.org/W2064880511","https://openalex.org/W2118405629","https://openalex.org/W2163167045","https://openalex.org/W2183490115","https://openalex.org/W2295111774","https://openalex.org/W2313202310","https://openalex.org/W2766312457","https://openalex.org/W2788006697","https://openalex.org/W2790882374","https://openalex.org/W2910372304","https://openalex.org/W2913129194","https://openalex.org/W2944761196","https://openalex.org/W3014721277","https://openalex.org/W3133405894","https://openalex.org/W3154312274"],"related_works":["https://openalex.org/W3198704259","https://openalex.org/W3169130436","https://openalex.org/W3041173824","https://openalex.org/W3023642864","https://openalex.org/W6926471726","https://openalex.org/W3200039975","https://openalex.org/W4404060276","https://openalex.org/W3049677807","https://openalex.org/W3097214788","https://openalex.org/W3128572634"],"abstract_inverted_index":{"According":[0],"to":[1,29,55,174,180],"statistics,":[2],"81%":[3],"of":[4,6,24,27,59,71,74,78,91,102,108,115,133,148,155,159],"cases":[5],"COVID-19":[7,183],"coronavirus":[8],"infection":[9],"occur":[10],"in":[11,83,126,145],"a":[12,30,42,62,72,86],"mild":[13],"or":[14],"moderate":[15],"form.":[16],"These":[17],"patients":[18,149,181],"make":[19],"up":[20],"the":[21,25,34,48,52,56,69,75,79,95,105,113,116,130,134,137,156,160,168],"main":[22],"part":[23],"flow":[26],"calls":[28],"general":[31],"practitioner":[32],"at":[33],"moment.":[35],"The":[36,66,152,164],"difficulties":[37],"that":[38,167],"therapists":[39],"face":[40],"during":[41],"pandemic":[43],"are":[44,112],"associated":[45],"with":[46,150,182],"finding":[47],"optimal":[49],"therapy":[50,147],"for":[51,122],"disease":[53],"due":[54],"gradual":[57],"accumulation":[58],"knowledge":[60],"about":[61],"new":[63],"RNA-containing":[64],"virus.":[65],"article":[67],"presents":[68],"data":[70,170],"study":[73,128],"antiviral":[76,106,131],"activity":[77,132],"drug":[80,117,135,161],"Lysobact":[81,118],"Complete\u00ae":[82,119],"vitro":[84,127],"on":[85,136],"Vero":[87],"cell":[88],"culture.":[89],"Studies":[90],"previous":[92],"years":[93],"confirm":[94],"antiviral,":[96],"anti-inflammatory,":[97],"strengthening":[98],"local":[99],"immunity":[100],"effect":[101,107],"lysozyme":[103],"hydrochloride,":[104],"cetylpyridinium":[109],"chloride,":[110],"both":[111],"components":[114],"dosed":[120],"spray":[121],"topical":[123],"use.":[124],"This":[125],"confirmed":[129],"SARS-CoV-2":[138],"virus,":[139],"which":[140],"makes":[141],"its":[142],"use":[143,158],"promising":[144],"complex":[146],"COVID-19.":[151],"theoretical":[153],"justification":[154],"practical":[157],"is":[162],"given.":[163],"authors":[165],"hope":[166],"research":[169],"will":[171],"be":[172],"useful":[173],"doctors":[175],"when":[176],"providing":[177],"medical":[178],"care":[179]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-12-31T00:00:00"}